NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX) – yesterday announced a 15,000 square foot expansion at its Windham, Maine antibody production facility. The expansion enables the Company to meet surging demand for the Company’s Genomic Antibody Technology™ (GAT) platform, particularly following the launch of its oncology-focused, Internet-based catalog of antibody reagents (http://antibodies.sdix.com).
